- Home
- IPHA vs USGO Comparison
IPHA vs USGO Comparison
Compare IPHA & USGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPHA
- USGO
- Stock Information
- Founded
- IPHA 1999
- USGO 2015
- Country
- IPHA France
- USGO Canada
- Employees
- IPHA N/A
- USGO N/A
- Industry
- IPHA Biotechnology: Pharmaceutical Preparations
- USGO Precious Metals
- Sector
- IPHA Health Care
- USGO Basic Materials
- Exchange
- IPHA Nasdaq
- USGO Nasdaq
- Market Cap
- IPHA 148.3M
- USGO 120.6M
- IPO Year
- IPHA 2019
- USGO 2023
- Fundamental
- Price
- IPHA $1.77
- USGO $9.37
- Analyst Decision
- IPHA Strong Buy
- USGO Strong Buy
- Analyst Count
- IPHA 1
- USGO 1
- Target Price
- IPHA $11.50
- USGO $26.50
- AVG Volume (30 Days)
- IPHA 42.3K
- USGO 22.3K
- Earning Date
- IPHA 09-12-2024
- USGO 02-19-2025
- Dividend Yield
- IPHA N/A
- USGO N/A
- EPS Growth
- IPHA N/A
- USGO N/A
- EPS
- IPHA N/A
- USGO N/A
- Revenue
- IPHA $36,202,722.00
- USGO N/A
- Revenue This Year
- IPHA N/A
- USGO N/A
- Revenue Next Year
- IPHA $101.65
- USGO N/A
- P/E Ratio
- IPHA N/A
- USGO N/A
- Revenue Growth
- IPHA N/A
- USGO N/A
- 52 Week Low
- IPHA $1.29
- USGO $5.00
- 52 Week High
- IPHA $3.51
- USGO $14.46
- Technical
- Relative Strength Index (RSI)
- IPHA 46.55
- USGO 53.48
- Support Level
- IPHA $1.65
- USGO $7.26
- Resistance Level
- IPHA $1.87
- USGO $8.80
- Average True Range (ATR)
- IPHA 0.12
- USGO 0.75
- MACD
- IPHA -0.03
- USGO 0.20
- Stochastic Oscillator
- IPHA 33.47
- USGO 77.29
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About USGO U.S. GoldMining Inc. Common stock
US Goldmining Inc is a mineral exploration and development company. It is focused on the exploration and development of a project located in Alaska, USA. The company's sole property is Whistler Project which is a gold-copper exploration project located in the Yentna Mining District, approximately 170 km northwest of Anchorage, Alaska.